Gregg Feinerman, M.D., Inc. – Trademark Portfolio
Entity Type: 03
Gregg Feinerman, M.D., Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SEE YOUNG. FEEL YOUNG. and FEINERMAN VISION CENTER. The owner is based in Newport Beach, CA.
320 Superior Avenue, Suite #350
Newport Beach, CA 92663
Showing of trademarks Trademarks
Trademark Classifications
Gregg Feinerman, M.D., Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Gregg Feinerman, M.D., Inc. have?
Gregg Feinerman, M.D., Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 cancelled.
What trademark classes does Gregg Feinerman, M.D., Inc. file in?
Gregg Feinerman, M.D., Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 35 (Advertising & Business). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Gregg Feinerman, M.D., Inc.'s most well-known trademarks?
Gregg Feinerman, M.D., Inc.'s registered trademark portfolio includes well-known marks such as SEE YOUNG. FEEL YOUNG. and FEINERMAN VISION CENTER. These are among 2 currently registered trademarks in the portfolio.
What is Gregg Feinerman, M.D., Inc.'s trademark registration success rate?
Gregg Feinerman, M.D., Inc. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.